AKAP1: A Protein Kinase Target for Therapeutic Intervention (G8165)

Target Name: AKAP1

NCBI ID: G8165

AKAP1: A Protein Kinase Target for Therapeutic Intervention

Introduction

Protein kinase A1 (AKAP1) is a key regulator of cell proliferation, survival, and angiogenesis, which is vital for various physiological processes in the body. It is a 21-kDa protein that is expressed in various tissues, including brain, heart, kidney , and pancreas. The AKAP1 gene has four splice variants, which result in different isoforms of the protein. The most abundant is the protein kinase A1 isoform, which is involved in various cellular processes.

Disease-Causeation Relationship

AKAP1 is implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its involvement in these diseases has led to the search for new therapeutic approaches. The increasing evidence in the role of AKAP1 in diseases has also led to the exploration of AKAP1 as a potential drug target or biomarker.

The Potential as a Drug Target

The potential of AKAP1 as a drug target is based on its role in various cellular processes, including cell proliferation, survival, and angiogenesis. Several studies have shown that AKAP1 is involved in the regulation of cell cycle progression, apoptosis, and angiogenesis, which are crucial for the development and progression of various diseases.

In cancer, AKAP1 has been shown to promote the growth and survival of cancer cells. Several studies have shown that overexpression of AKAP1 can lead to the development of cancer cells. For example, a study by Li et al. found that overexpression of AKAP1 in human breast cancer cells led to the formation of tumors.

In neurodegenerative diseases, AKAP1 has been shown to contribute to the development and progression of neurodegenerative diseases. For example, a study by Zhang et al. found that overexpression of AKAP1 in mouse models of Alzheimer's disease led to the development of neurodegeneration.

In autoimmune disorders, AKAP1 has been shown to play a role in the development and progression of autoimmune disorders. For example, a study by Wang et al. found that overexpression of AKAP1 in mouse models of rheumatoid arthritis led to the development of joint inflammation and disease.

The Potential as a Biomarker

The potential of AKAP1 as a biomarker is based on its role in various cellular processes, including cell proliferation, survival, and angiogenesis. Several studies have shown that AKAP1 can be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In cancer, AKAP1 has been shown to be involved in the regulation of cell cycle progression and apoptosis. For example, a study by Zhang et al. found that overexpression of AKAP1 in human breast cancer cells led to the formation of tumors, and the expression of AKAP1 was significantly increased in the tumors compared to the normal cells.

In neurodegenerative diseases, AKAP1 has been shown to contribute to the development and progression of neurodegenerative diseases. For example, a study by Li et al. found that overexpression of AKAP1 in mouse models of Alzheimer's disease led to the development of neurodegeneration, and the expression of AKAP1 was significantly increased in the neurodegenerate mice compared to the normal mice.

In autoimmune disorders, AKAP1 has been shown to play a role in the development and progression of autoimmune disorders. For example, a study by Wang et al. found that overexpression of AKAP1 in mouse models of rheumatoid arthritis led to the development of joint inflammation and disease, and the expression of AKAP1 was significantly increased in the rheumatoid arthritis mice compared to the normal mice.

Conclusion

In conclusion, AKAP1 is a protein kinase that is involved in various cellular processes, including

Protein Name: A-kinase Anchoring Protein 1

Functions: Binds to type I and II regulatory subunits of protein kinase A and anchors them to the cytoplasmic face of the mitochondrial outer membrane (By similarity). Involved in mitochondrial-mediated antiviral innate immunity (PubMed:31522117). Promotes translocation of NDUFS1 into mitochondria to regulate mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) activity (By similarity)

More Common Targets